Equibles does not estimate personal net worth.
Get an email with a short summary when West Pharmaceutical Services Inc publishes a filing, an earnings call transcript or a press release.
Get WST alertsRobert McMahon is recorded as CFO at West Pharmaceutical Services Inc (WST). West Pharmaceutical Services Inc reported in an 8-K filed July 21, 2025 that Robert McMahon was appointed Senior Vice President & Chief Financial Officer, effective August 4, 2025. Robert McMahon has spoken on 4 earnings calls and 2 other investor events across 1 company, most recently for West Pharmaceutical Services Inc on October 29, 2026. West Pharmaceutical Services Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at West Pharmaceutical Services Inc includes Michel Lagarde (CEO and Board Member), Robert F. Friel (Chairman and Board Member), Kimberly Banks MacKay (General Counsel) and 7 others.
“On July 21, 2025, West Pharmaceutical Services, Inc. (the "Company") announced the appointment of Robert McMahon as Senior Vice President & Chief Financial Officer, effective as of August 4, 2025 (the "Commencement Date").”
“Today, I'll provide some additional details on Q3 revenue and take you through the income statement and some other key financial metrics. I'll then cover our updated outlook for the rest of the year.”
“Yeah, we were really pleased with how Q2 shaped up despite the fact of the cyber incident. We were able to overcome that and actually beat expectations, as you mentioned.”
“This morning, I'll provide some additional details on Q2 revenue and take you through the income statement and some other key financial metrics. I'll then cover our updated full year and third quarter guidance.”
“We made measures to ensure that the data that had been exfiltrated is not going to be disseminated. So we feel good about that. And then we're still finalizing the plans of when the sites are coming up.”
“This morning, I'll provide some additional details on Q1 revenue and take you through the income statement and some other key financial metrics. I'll then cover our updated full year and second quarter guidance.”
Medical Instruments & Supplies · Healthcare
CFO
